- Home
- FBP vs PRCT Comparison
FBP vs PRCT Comparison
Compare FBP & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBP
- PRCT
- Stock Information
- Founded
- FBP 1948
- PRCT 2009
- Country
- FBP United States
- PRCT United States
- Employees
- FBP N/A
- PRCT N/A
- Industry
- FBP Major Banks
- PRCT Medical Specialities
- Sector
- FBP Finance
- PRCT Health Care
- Exchange
- FBP Nasdaq
- PRCT Nasdaq
- Market Cap
- FBP 2.9B
- PRCT 2.9B
- IPO Year
- FBP N/A
- PRCT 2021
- Fundamental
- Price
- FBP $18.25
- PRCT $53.03
- Analyst Decision
- FBP Buy
- PRCT Strong Buy
- Analyst Count
- FBP 4
- PRCT 7
- Target Price
- FBP $22.00
- PRCT $91.43
- AVG Volume (30 Days)
- FBP 1.8M
- PRCT 1.0M
- Earning Date
- FBP 04-24-2025
- PRCT 04-24-2025
- Dividend Yield
- FBP 3.95%
- PRCT N/A
- EPS Growth
- FBP 5.85
- PRCT N/A
- EPS
- FBP 1.81
- PRCT N/A
- Revenue
- FBP $879,847,000.00
- PRCT $224,498,000.00
- Revenue This Year
- FBP $2.90
- PRCT $46.28
- Revenue Next Year
- FBP $6.97
- PRCT $32.67
- P/E Ratio
- FBP $10.08
- PRCT N/A
- Revenue Growth
- FBP 1.92
- PRCT 64.84
- 52 Week Low
- FBP $16.25
- PRCT $47.04
- 52 Week High
- FBP $22.40
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- FBP 49.03
- PRCT 42.69
- Support Level
- FBP $17.76
- PRCT $51.27
- Resistance Level
- FBP $18.34
- PRCT $54.75
- Average True Range (ATR)
- FBP 0.76
- PRCT 3.64
- MACD
- FBP 0.04
- PRCT 0.19
- Stochastic Oscillator
- FBP 62.08
- PRCT 49.48
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.